Featured Research

from universities, journals, and other organizations

New Preservative Increases Shelf Life Of Blood Platelets, Decreases Risk Of Harmful Reactions

Date:
June 1, 2006
Source:
Lifespan
Summary:
A new study has found that storing whole blood derived platelets in an artificial preservative can extend their shelf life and produce a safer end product. This is the finding of a research paper appearing in the May 2006 issue of Transfusion by researchers at The Miriam Hospital in Providence, RI.

A new study has found that storing whole blood derived platelets in an artificial preservative can extend their shelf life and produce a safer end product. This is the finding of a research paper appearing in the May 2006 issue of Transfusion by researchers at The Miriam Hospital in Providence, RI.

In the wake of mass casualties from either natural disasters, such as the earthquake in Indonesia, or combat situations in Iraq and Afghanistan—extending the shelf life of platelets could have global implications for those in critical need of the blood product.

Platelets are the component of whole blood that control bleeding and prevent life-threatening hemorrhages. Patients undergoing a bone marrow transplant, cardiac surgery, chemotherapy, radiation treatment or organ transplants often require platelet transfusions.

"We found that by storing the platelets in the artificial preservative, we were able to retain the quality of the blood product for seven days, as opposed to having to dispose of them after only five days," says lead author Joseph Sweeney, MD, director of transfusion services at The Miriam Hospital and professor at Brown Medical School.

In addition, Sweeney and his team were able to reduce up to 80 percent of the plasma in the platelets stored in preservative. Since plasma is responsible for the majority of the adverse reactions that transfusion patients may experience, this suggests that those receiving transfusions will better tolerate the new blood product.

Sweeney explains, "Currently, platelets are stored in plasma and discarded after five days. Significantly reducing the amount of plasma would likely lessen the frequency of these adverse events."

The authors write that inadequate inventories of platelets due to their short shelf life and highly unpredictable demand, greatly limits blood centers' ability to provide platelets for essential transfusions. With a storage potential of seven days or longer, platelets can be more readily available to patients and provide a cost-savings to blood banks which discard millions of dollars worth of outdated platelets each year.

Researchers monitored two groups of platelets derived from whole blood donations. The first group of platelets was stored in plasma, while the second group was stored in the artificial preservative. On day seven, both groups of platelets met the current FDA requirements and the more stringent European requirements for use. Although both groups of platelets retained their quality for seven days, it's important to note that the platelets in the preservative had extremely low plasma levels.

The artificial preservative tested was unique because it contained glucose, which seems to be a key component in extending the shelf life of platelets. The preservative also contained sodium acetate and sodium bicarbonate.

"Until now, preservatives containing glucose have not been successfully used for platelet storage because glucose carmelizes during sterilization, and the only way to prevent carmelization is to lower the pH levels to a point that could be harmful to the platelet," says Sweeney.

Sweeney was able to use a glucose containing preservative without harming the platelets by adding sodium bicarbonate to the storage container. The sodium bicarbonate protected the platelets from exposure to low pH levels.

"Improvements in the quality and safety of blood products are continually being developed to enhance patient safety," Sweeney says. "Advances in platelet storage will pave the way for the next generation of blood products, such as artificial platelets."

The research was supported by a grant from Pall Corporation.


Story Source:

The above story is based on materials provided by Lifespan. Note: Materials may be edited for content and length.


Cite This Page:

Lifespan. "New Preservative Increases Shelf Life Of Blood Platelets, Decreases Risk Of Harmful Reactions." ScienceDaily. ScienceDaily, 1 June 2006. <www.sciencedaily.com/releases/2006/06/060601093034.htm>.
Lifespan. (2006, June 1). New Preservative Increases Shelf Life Of Blood Platelets, Decreases Risk Of Harmful Reactions. ScienceDaily. Retrieved October 20, 2014 from www.sciencedaily.com/releases/2006/06/060601093034.htm
Lifespan. "New Preservative Increases Shelf Life Of Blood Platelets, Decreases Risk Of Harmful Reactions." ScienceDaily. www.sciencedaily.com/releases/2006/06/060601093034.htm (accessed October 20, 2014).

Share This



More Health & Medicine News

Monday, October 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
Fauci: Ebola Protocols to Focus on Training

Fauci: Ebola Protocols to Focus on Training

AP (Oct. 20, 2014) Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, says he expects revised CDC protocols on Ebola to focus on training, observation and ensuring health care workers are more protected. (Oct. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins